$2.5 Billion is the total value of Perceptive Advisors's 316 reported holdings in Q3 2015. The portfolio turnover from Q2 2015 to Q3 2015 was 54.9% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| FOLD | Buy | AMICUS THERAPEUTICS INC | $351,266,000 | +71.9% | 28,878,888 | +100.0% | 14.03% | +14.1% |
| NBIX | Buy | NEUROCRINE BIOSCIENCES INC | $234,202,000 | +49.3% | 5,885,934 | +79.2% | 9.36% | -0.9% |
| SRPT | Buy | SAREPTA THERAPEUTICS INC | $178,848,000 | +109.2% | 5,569,856 | +98.2% | 7.15% | +38.8% |
| RTRX | Buy | RETROPHIN INC | $107,258,000 | +17.0% | 5,294,160 | +87.7% | 4.28% | -22.4% |
| TSRO | Buy | TESARO INC | $78,736,000 | +60.3% | 1,963,518 | +135.1% | 3.15% | +6.4% |
| GBT | New | GLOBAL BLOOD THERAPEUTICS IN | $77,726,000 | – | 1,843,600 | +100.0% | 3.10% | – |
| DYAX | Buy | DYAX CORP | $62,856,000 | +32.8% | 3,292,630 | +84.3% | 2.51% | -11.9% |
| NVRO | Buy | NEVRO CORP | $56,300,000 | +31.1% | 1,213,622 | +51.9% | 2.25% | -13.0% |
| GWPH | New | GW PHARMACEUTICALS -ADRput | $54,822,000 | – | 600,000 | +100.0% | 2.19% | – |
| PTCT | New | PTC THERAPEUTICS INCput | $53,668,000 | – | 2,010,000 | +100.0% | 2.14% | – |
| VSAR | Buy | VERSARTIS INC | $53,452,000 | +165.8% | 4,635,908 | +250.8% | 2.14% | +76.4% |
| IWM | New | ISHARES RUSSELL 2000put | $43,680,000 | – | 400,000 | +100.0% | 1.74% | – |
| XNCR | Buy | XENCOR INC | $42,922,000 | +3.7% | 3,509,568 | +86.2% | 1.72% | -31.2% |
| ACRX | Buy | ACELRX PHARMACEUTICALS INC | $38,210,000 | +37.1% | 12,528,120 | +90.6% | 1.53% | -9.1% |
| RLYP | Buy | RELYPSA INC | $36,574,000 | -3.0% | 1,975,884 | +73.5% | 1.46% | -35.6% |
| LJPC | Buy | LA JOLLA PHARMACEUTICAL CO | $36,378,000 | +486.8% | 1,309,030 | +417.6% | 1.45% | +289.5% |
| RGNX | New | REGENXBIO INC | $34,332,000 | – | 1,558,426 | +100.0% | 1.37% | – |
| XBI | Buy | STREETTRACKS SPDR BIOTEC ETFput | $34,238,000 | -9.5% | 550,000 | +266.7% | 1.37% | -39.9% |
| LBIO | Buy | LION BIOTECHNOLOGIES INC | $34,046,000 | +34.5% | 5,910,912 | +114.2% | 1.36% | -10.8% |
| RXDX | Buy | IGNYTA INC | $33,918,000 | +14.2% | 3,863,200 | +96.3% | 1.36% | -24.2% |
| CEMP | Buy | CEMPRA INC | $32,434,000 | +64.9% | 1,165,000 | +103.5% | 1.30% | +9.4% |
| PFNX | Buy | PFENEX INC | $29,150,000 | +48.6% | 1,942,086 | +92.1% | 1.16% | -1.4% |
| QURE | Buy | UNIQURE NV | $28,232,000 | +60.8% | 1,380,538 | +112.3% | 1.13% | +6.7% |
| SSO | Buy | PROSHARES ULTRA S & P500put | $22,240,000 | +589.2% | 400,000 | +700.0% | 0.89% | +358.2% |
| CSU | Buy | CAPITAL SR LIVING CORP | $22,200,000 | +41.5% | 1,107,200 | +72.9% | 0.89% | -6.1% |
| DERM | Buy | DERMIRA INC | $22,032,000 | +725.8% | 944,000 | +521.1% | 0.88% | +446.6% |
| DBVT | Buy | DBV TECHNOLOGIES S Asponsored adr | $21,832,000 | +24430.3% | 613,430 | +20334.0% | 0.87% | +17340.0% |
| NVO | New | NOVO-NORDISK A/S-SPONS ADRput | $21,696,000 | – | 400,000 | +100.0% | 0.87% | – |
| QTNT | Buy | QUOTIENT LTD | $20,694,000 | +141.3% | 1,553,606 | +176.2% | 0.83% | +60.3% |
| GILD | GILEAD SCIENCES INCput | $19,638,000 | -16.1% | 200,000 | 0.0% | 0.78% | -44.3% | |
| Buy | ACADIA PHARMACEUTICALS INC | $19,528,000 | +13.7% | 590,480 | +43.9% | 0.78% | -24.6% | |
| SRPT | Buy | Sarepta Therapeutics Inccall | $19,268,000 | +26.6% | 600,000 | +20.0% | 0.77% | -15.9% |
| CDTX | Buy | CIDARA THERAPEUTICS INC | $18,898,000 | +349.3% | 1,485,716 | +395.2% | 0.76% | +198.4% |
| EGRX | Buy | EAGLE PHARMACEUTICALS INC | $18,218,000 | -3.3% | 246,088 | +5.6% | 0.73% | -35.9% |
| TEVA | New | TEVA PHARMACEUTICAL INDS LTDadr | $18,068,000 | – | 320,000 | +100.0% | 0.72% | – |
| BPMC | Buy | BLUEPRINT MEDICINES CORP | $17,258,000 | +61.1% | 808,808 | +100.0% | 0.69% | +7.0% |
| VBIV | Buy | VBI VACCINES INC | $17,214,000 | +152.7% | 6,520,712 | +149.8% | 0.69% | +67.8% |
| SHPG | Buy | SHIRE PLCsponsored adr | $16,830,000 | +74.2% | 82,000 | +105.0% | 0.67% | +15.5% |
| ZYNE | New | ZYNERBA PHARMACEUTICALS INC | $16,580,000 | – | 1,158,700 | +100.0% | 0.66% | – |
| NEOS | New | NEOS THERAPEUTICS INC | $15,592,000 | – | 742,132 | +100.0% | 0.62% | – |
| Buy | ASSEMBLY BIOSCIENCES INC | $15,200,000 | +0.5% | 1,590,000 | +102.6% | 0.61% | -33.3% | |
| Buy | BELLICUM PHARMACEUTICALS INC | $15,144,000 | +28.8% | 1,042,376 | +88.6% | 0.60% | -14.5% | |
| NEPT | Buy | NEPTUNE TECHNOLOGIES BIORESO | $14,740,000 | +70.5% | 13,400,888 | +100.0% | 0.59% | +13.3% |
| ABEO | Buy | ABEONA THERAPEUTICS INC | $14,280,000 | +500.5% | 3,525,762 | +650.2% | 0.57% | +299.3% |
| Buy | ANI PHARMACEUTICALS INCnote 3.000%12/0 | $13,846,000 | +63.1% | 15,000,000 | +100.0% | 0.55% | +8.2% | |
| XLRN | Buy | ACCELERON PHARMA INC | $13,746,000 | +57.4% | 552,072 | +100.0% | 0.55% | +4.4% |
| THOR | Buy | THORATEC CORPcall | $12,654,000 | +183.9% | 200,000 | +100.0% | 0.51% | +88.8% |
| Buy | ALLIQUA BIOMEDICAL INC | $12,184,000 | +20.3% | 3,843,902 | +100.0% | 0.49% | -20.2% | |
| CLLS | Buy | CELLECTIS S Asponsored ads | $11,528,000 | +76.0% | 437,358 | +141.0% | 0.46% | +17.0% |
| AGTC | Buy | APPLIED GENETIC TECHNOL CORP | $11,182,000 | +142.2% | 1,701,984 | +465.6% | 0.45% | +60.8% |
| Buy | NEURODERM LTD | $11,162,000 | +263.6% | 540,000 | +170.0% | 0.45% | +141.1% | |
| ALDX | Buy | ALDEYRA THERAPEUTICS INC | $11,160,000 | +65.4% | 1,914,386 | +120.1% | 0.45% | +9.9% |
| RLYP | New | RELYPSA INCcall | $11,106,000 | – | 600,000 | +100.0% | 0.44% | – |
| Buy | ARDELYX INC | $10,920,000 | +116.4% | 631,910 | +100.0% | 0.44% | +43.4% | |
| THOR | Sell | THORATEC CORP | $10,880,000 | +8.0% | 172,000 | -23.9% | 0.44% | -28.3% |
| AFMD | Buy | AFFIMED N V | $10,722,000 | -22.3% | 1,737,240 | +69.7% | 0.43% | -48.4% |
| AXGT | Buy | AXOVANT SCIENCES LTD | $10,594,000 | +173.6% | 820,000 | +331.6% | 0.42% | +81.5% |
| ANTH | Buy | ANTHERA PHARMACEUTICALS INC | $10,412,000 | +0.5% | 1,984,312 | +65.1% | 0.42% | -33.3% |
| TKAI | Buy | TOKAI PHARMACEUTICALS INC | $10,048,000 | +55.7% | 970,676 | +100.0% | 0.40% | +3.1% |
| RLYP | New | RELYPSA INCput | $9,256,000 | – | 500,000 | +100.0% | 0.37% | – |
| FPRX | Buy | FIVE PRIME THERAPEUTICS INC | $8,746,000 | +57.1% | 568,258 | +153.5% | 0.35% | +4.2% |
| NERV | Buy | MINVERA NEUROSCIENCES | $8,510,000 | +81.0% | 1,621,074 | +100.0% | 0.34% | +20.1% |
| TRXC | Buy | TRANSENTERIX INC | $8,254,000 | +34.6% | 3,652,864 | +78.7% | 0.33% | -10.6% |
| PRTO | Buy | PROTEON THERAPEUTICS INC | $7,650,000 | +55.7% | 550,000 | +100.0% | 0.31% | +3.4% |
| HEWG | Buy | ISHARES TRhdg msci germn | $6,580,000 | +189.9% | 290,000 | +233.3% | 0.26% | +92.0% |
| STJ | New | ST JUDE MED INC | $6,502,000 | – | 103,040 | +100.0% | 0.26% | – |
| CYAD | Buy | CELYAD SAadr | $6,278,000 | +60.9% | 150,000 | +100.0% | 0.25% | +6.8% |
| WBA | Buy | WALGREENS BOOTS ALLIANCE INC | $5,866,000 | +96.8% | 70,584 | +100.0% | 0.23% | +30.7% |
| RGEN | New | REPLIGEN CORPput | $5,570,000 | – | 200,000 | +100.0% | 0.22% | – |
| PTCT | New | PTC THERAPEUTICS INCcall | $5,340,000 | – | 200,000 | +100.0% | 0.21% | – |
| CI | Buy | CIGNA CORPORATION | $5,258,000 | +47.7% | 38,940 | +77.2% | 0.21% | -1.9% |
| ARIA | Buy | ARIAD PHARMACEUTICALS INC | $5,256,000 | +231.2% | 900,000 | +368.9% | 0.21% | +118.8% |
| CPRX | Buy | CATALYST PHARMACEUTICALS INC | $5,108,000 | +45.3% | 1,702,400 | +100.0% | 0.20% | -3.8% |
| AKBA | New | AKEBIA THERAPEUTICS INC | $5,024,000 | – | 520,000 | +100.0% | 0.20% | – |
| MGCD | Buy | MGC DIAGNOSTICS CORP | $4,438,000 | +151.9% | 672,574 | +100.0% | 0.18% | +67.0% |
| VTAE | Buy | VITAE PHARMACEUTICALS INC | $4,404,000 | +103.9% | 400,000 | +166.7% | 0.18% | +35.4% |
| EVH | Buy | EVOLENT HEALTH INCcl a | $4,382,000 | +47.0% | 274,578 | +79.7% | 0.18% | -2.2% |
| ABEOW | Buy | ABEONA THERAPEUTICS INC*w exp 12/19/201 | $4,346,000 | +93.2% | 2,519,272 | +101.5% | 0.17% | +28.9% |
| CSBR | New | CHAMPIONS ONCOLOGY INC | $3,986,000 | – | 745,194 | +100.0% | 0.16% | – |
| New | INTEC PHARMA LTD JERUSALEM | $3,920,000 | – | 700,000 | +100.0% | 0.16% | – | |
| CRBP | Buy | CORBUS PHARMACEUTICALS INC | $3,924,000 | +46.5% | 2,500,000 | +187.4% | 0.16% | -2.5% |
| New | BAXTER INTL INC | $3,942,000 | – | 120,000 | +100.0% | 0.16% | – | |
| XENE | Buy | XENON PHARMACEUTICALS INC | $3,398,000 | +31.0% | 411,600 | +82.9% | 0.14% | -12.8% |
| DSCI | Buy | DERMA SCIENCES INC | $3,396,000 | -86.4% | 721,168 | +106.8% | 0.14% | -91.0% |
| RPRX | New | REPROS THERAPEUTICS INC | $3,270,000 | – | 440,000 | +100.0% | 0.13% | – |
| NVLS | New | NIVALIS THERAPEUTICS INC | $3,242,000 | – | 250,000 | +100.0% | 0.13% | – |
| Buy | AVINGER INC | $2,868,000 | +116.8% | 195,000 | +90.2% | 0.12% | +43.8% | |
| GNVC | Buy | GENVEC INC | $2,846,000 | +126.6% | 1,231,688 | +100.0% | 0.11% | +50.0% |
| BCRX | Sell | BIOCRYST PHARMACEUTICALS | $2,822,000 | -59.8% | 247,490 | -47.3% | 0.11% | -73.3% |
| UUP | Buy | POWERSHS DB US DOLLAR INDEXdoll indx bull | $2,762,000 | +22.6% | 110,000 | +22.2% | 0.11% | -19.1% |
| ONTY | Buy | ONCOTHYREON INC | $2,760,000 | -77.9% | 7,093,794 | +112.0% | 0.11% | -85.4% |
| SCYX | Buy | SCYNEXIS INC | $2,548,000 | +65.7% | 350,000 | +100.0% | 0.10% | +9.7% |
| NVTA | Buy | INVITAE CORP | $2,431,000 | +5.4% | 336,666 | +12.4% | 0.10% | -30.2% |
| SGYPQ | New | SYNERGY PHARMACEUTICALS DEL | $2,396,000 | – | 452,000 | +100.0% | 0.10% | – |
| XIV | Buy | CREDIT SUISSE NASSAU BRHinvrs vix sterm | $2,264,000 | +1297.5% | 93,000 | +2225.0% | 0.09% | +800.0% |
| VCEL | Buy | VERICEL CORP | $1,904,000 | +0.9% | 702,324 | +32.8% | 0.08% | -33.3% |
| BCLI | Buy | BRAINSTORM CELL THERAPEUTICS | $1,832,000 | +26.9% | 800,000 | +100.0% | 0.07% | -16.1% |
| IRWD | Sell | IRONWOOD PHARMACEUTICALS INC | $1,798,000 | -69.8% | 172,458 | -65.1% | 0.07% | -79.9% |
| SAGE | Buy | SAGE THERAPEUTICS INC | $1,694,000 | +16.0% | 40,000 | +100.0% | 0.07% | -22.7% |
| AQXP | Sell | AQUINOX PHARMACEUTICALS INC | $1,678,000 | +86.0% | 119,200 | -8.3% | 0.07% | +24.1% |
| CGNT | Buy | COGENTIX MED INC | $1,670,000 | +53.1% | 1,346,514 | +100.0% | 0.07% | +1.5% |
| FCAU | Buy | FIAT CHRYSLER AUTOMOBILES N | $1,638,000 | +81.8% | 124,000 | +100.0% | 0.06% | +20.4% |
| ANIP | Sell | ANI PHARMACEUTICALS INC | $1,522,000 | -92.5% | 38,512 | -88.2% | 0.06% | -95.0% |
| Buy | ARNO THERAPEUTICS INC | $1,424,000 | +16.6% | 4,069,442 | +100.0% | 0.06% | -23.0% | |
| STML | Buy | STEMLINE THERAPEUTICS INC | $1,388,000 | +48.8% | 157,206 | +98.4% | 0.06% | -1.8% |
| ACST | Buy | ACASTI PHARMA INC | $1,252,000 | +68.1% | 4,731,200 | +100.0% | 0.05% | +11.1% |
| XNCR | New | XENCOR INCput | $1,224,000 | – | 100,000 | +100.0% | 0.05% | – |
| GLMD | Buy | GALMED PHARMACEUTICALS LTD | $1,114,000 | +47.5% | 150,000 | +100.0% | 0.04% | 0.0% |
| SNSS | Buy | SUNESIS PHARMACEUTICALS INC | $1,134,000 | -46.2% | 1,400,000 | +100.0% | 0.04% | -64.6% |
| TBT | New | PROSHARES TR | $1,040,000 | – | 24,000 | +100.0% | 0.04% | – |
| QTNTW | New | QUOTIENT LTD*w exp 10/30/201 | $950,000 | – | 262,502 | +100.0% | 0.04% | – |
| DRNA | Buy | DICERNA PHARMACEUTICALS INC | $822,000 | +17.8% | 100,000 | +100.0% | 0.03% | -21.4% |
| Buy | TRILLIUM THERAPEUTICS INC | $782,000 | +19.4% | 60,000 | +100.0% | 0.03% | -20.5% | |
| OTIC | Buy | OTONOMY INC | $728,000 | -91.4% | 370,736 | +0.9% | 0.03% | -94.3% |
| Buy | ACHAOGEN INC | $692,000 | +91.2% | 120,000 | +100.0% | 0.03% | +27.3% | |
| BVX | Buy | BOVIE MEDICAL CORP | $644,000 | +33.6% | 325,400 | +88.4% | 0.03% | -10.3% |
| APHB | New | AMPLIPHI BIOSCIENCES | $632,000 | – | 160,000 | +100.0% | 0.02% | – |
| INCR | Buy | INC RESH HLDGS INCcl a | $580,000 | +99.3% | 14,522 | +100.0% | 0.02% | +27.8% |
| NVO | Buy | NOVO-NORDISK A Sadr | $580,000 | +353.1% | 10,680 | +356.4% | 0.02% | +187.5% |
| AET | Sell | AETNA INC NEW | $566,000 | -56.0% | 5,172 | -48.7% | 0.02% | -70.1% |
| LHCG | Buy | LHC GROUP INC | $530,000 | +134.5% | 11,834 | +100.0% | 0.02% | +50.0% |
| PSDV | Buy | PSIVIDA CORP | $514,000 | -56.7% | 630,000 | +100.0% | 0.02% | -70.4% |
| GB | Buy | GREATBATCH INC | $496,000 | +109.3% | 8,782 | +100.0% | 0.02% | +42.9% |
| GILD | Buy | GILEAD SCIENCES INC | $482,000 | +67.4% | 4,914 | +100.0% | 0.02% | +11.8% |
| New | ADDUS HOMECARE CORP | $474,000 | – | 15,202 | +100.0% | 0.02% | – | |
| HNT | Buy | HEALTH NET INC | $462,000 | +87.8% | 7,662 | +100.0% | 0.02% | +20.0% |
| TARO | Buy | TARO PHARMACEUTICAL INDS LTD | $426,000 | +98.1% | 2,986 | +100.0% | 0.02% | +30.8% |
| EW | New | EDWARDS LIFESCIENCES CORP | $426,000 | – | 3,000 | +100.0% | 0.02% | – |
| Buy | ANTHEM INC | $402,000 | +70.3% | 2,872 | +100.0% | 0.02% | +14.3% | |
| CAH | Buy | CARDINAL HEALTH INC | $396,000 | +84.2% | 5,148 | +100.0% | 0.02% | +23.1% |
| CNCE | New | CONCERT PHARMACEUTICALS INC | $390,000 | – | 20,758 | +100.0% | 0.02% | – |
| CRIS | New | CURIS INC | $404,000 | – | 200,000 | +100.0% | 0.02% | – |
| HCA | Sell | HCA HOLDINGS INC | $396,000 | -91.4% | 5,126 | -89.9% | 0.02% | -94.2% |
| MOH | Buy | MOLINA HEALTHCARE INC | $398,000 | +96.1% | 5,776 | +100.0% | 0.02% | +33.3% |
| PMC | Buy | PHARMERICA CORP | $388,000 | +71.7% | 13,600 | +100.0% | 0.02% | +14.3% |
| GTS | Buy | TRIPLE-S MGMT CORPcl b | $378,000 | +39.0% | 21,210 | +100.0% | 0.02% | -6.2% |
| WCG | New | WELLCARE HEALTH PLANS INC | $378,000 | – | 4,378 | +100.0% | 0.02% | – |
| MGLN | Buy | MAGELLAN HEALTH INC | $378,000 | +86.2% | 6,820 | +135.2% | 0.02% | +25.0% |
| ICLR | Buy | ICON PLC | $374,000 | +66.2% | 5,262 | +57.2% | 0.02% | +7.1% |
| CBM | Buy | CAMBREX CORP | $372,000 | +15.5% | 9,384 | +28.0% | 0.02% | -21.1% |
| LPNT | New | LIFEPOINT HEALTH INC | $358,000 | – | 5,044 | +100.0% | 0.01% | – |
| INFI | Sell | INFINITY PHARMACEUTICALS INC | $338,000 | -24.7% | 40,000 | -2.4% | 0.01% | -48.1% |
| New | AMGEN INC | $354,000 | – | 2,560 | +100.0% | 0.01% | – | |
| LCI | New | LANNET INC | $336,000 | – | 8,096 | +100.0% | 0.01% | – |
| SCMP | New | SUCAMPO PHARMACEUTICALS INCcl a | $314,000 | – | 15,810 | +100.0% | 0.01% | – |
| REPH | New | RECRO PHARMA INC | $290,000 | – | 24,126 | +100.0% | 0.01% | – |
| DVCR | Buy | DIVERSICARE HEALTHCARE SVCS | $254,000 | +28.3% | 24,674 | +60.9% | 0.01% | -16.7% |
| AMAG | New | AMAG PHARMACEUTICALS INC | $230,000 | – | 5,808 | +100.0% | 0.01% | – |
| MYGN | Buy | MYRIAD GENETICS INC | $188,000 | +121.2% | 5,000 | +100.0% | 0.01% | +60.0% |
| ELGX | Sell | ENDOLOGIX INC | $142,000 | -97.1% | 11,510 | -96.4% | 0.01% | -98.0% |
| NSPH | Buy | NANOSPHERE INC | $116,000 | +0.9% | 70,758 | +100.0% | 0.01% | -28.6% |
| JNP | Sell | JUNIPER PHARMACEUTICALS INC | $40,000 | -90.3% | 3,472 | -92.3% | 0.00% | -92.0% |
| NUVA | New | NUVASIVE INC | $24,000 | – | 504 | +100.0% | 0.00% | – |
| CAPR | Buy | CAPRICOR THERAPEUTICS INC | $32,000 | +60.0% | 8,000 | +100.0% | 0.00% | 0.0% |
| VRX | New | VALEANT PHARMACEUTICALS INTERNATIONAL INcall | $36,000 | – | 200 | +100.0% | 0.00% | – |
| CNAT | Sell | CONATUS PHARMACEUTICALS INC | $4,000 | -99.2% | 850 | -99.2% | 0.00% | -100.0% |
| XBI | New | STREETTRACKS SPDR BIOTEC ETFcall | $12,000 | – | 200 | +100.0% | 0.00% | – |
| IDRA | New | IDERA PHARMACEUTICALS INC | $10,000 | – | 3,074 | +100.0% | 0.00% | – |
| PCRX | Exit | PACIRA PHARMACEUTICALS INC | $0 | – | -50 | -100.0% | 0.00% | – |
| NEOT | Exit | NEOTHETICS INC | $0 | – | -20,000 | -100.0% | -0.01% | – |
| ASND | Exit | ASCENDIS PHARMA A Ssponsored adr | $0 | – | -10,000 | -100.0% | -0.01% | – |
| UNH | Exit | UNITEDHEALTH GROUP INC | $0 | – | -1,685 | -100.0% | -0.01% | – |
| SURG | Exit | SYNERGETICS USA INC | $0 | – | -44,266 | -100.0% | -0.01% | – |
| ENTA | Exit | ENANTA PHARMACEUTICALS INC | $0 | – | -4,956 | -100.0% | -0.01% | – |
| LMAT | Exit | LEMAITRE VASCULAR INC | $0 | – | -19,838 | -100.0% | -0.01% | – |
| MCK | Exit | MCKESSON CORP | $0 | – | -1,015 | -100.0% | -0.01% | – |
| CYH | Exit | COMMUNITY HEALTH SYS INC NEW | $0 | – | -3,978 | -100.0% | -0.02% | – |
| PAHC | Exit | PHIBRO ANIMAL HEALTH CORP | $0 | – | -6,809 | -100.0% | -0.02% | – |
| UHS | Exit | UNIVERSAL HLTH SVCS INCcl b | $0 | – | -1,883 | -100.0% | -0.02% | – |
| MRGE | Exit | MERGE HEALTHCARE INC | $0 | – | -55,015 | -100.0% | -0.02% | – |
| XENT | Exit | INTERSECT ENT INC | $0 | – | -10,251 | -100.0% | -0.02% | – |
| SUPN | Exit | SUPERNUS PHARMACEUTICALS INC | $0 | – | -19,470 | -100.0% | -0.02% | – |
| PARNF | Exit | PARNELL PHARMACEUT HLDGS LTD | $0 | – | -68,800 | -100.0% | -0.02% | – |
| KERX | Exit | KERYX BIOPHARMACEUTICALS INC | $0 | – | -34,380 | -100.0% | -0.02% | – |
| OREX | Exit | OREXIGEN THERAPEUTICS INC | $0 | – | -70,600 | -100.0% | -0.02% | – |
| CNMD | Exit | CONMED CORP | $0 | – | -8,554 | -100.0% | -0.03% | – |
| THC | Exit | TENET HEALTHCARE CORP | $0 | – | -8,500 | -100.0% | -0.03% | – |
| Exit | ABIOMED INC | $0 | – | -10,000 | -100.0% | -0.04% | – | |
| DHR | Exit | DANAHER CORP DEL | $0 | – | -10,000 | -100.0% | -0.05% | – |
| IMPR | Exit | IMPRIVATA INC | $0 | – | -60,000 | -100.0% | -0.06% | – |
| GLPG | Exit | GALAPAGOS NVspon adr | $0 | – | -20,000 | -100.0% | -0.06% | – |
| TCON | Exit | TRACON PHARMACEUTICALS INC | $0 | – | -100,000 | -100.0% | -0.08% | – |
| EPZM | Exit | EPIZYME INC | $0 | – | -60,000 | -100.0% | -0.09% | – |
| INCY | Exit | INCYTE CORP | $0 | – | -15,000 | -100.0% | -0.09% | – |
| SSO | Exit | PROSHARES TR | $0 | – | -30,000 | -100.0% | -0.12% | – |
| MCRB | Exit | SERES THERAPEUTICS INC | $0 | – | -50,000 | -100.0% | -0.12% | – |
| RGLS | Exit | REGULUS THERAPEUTICS INCput | $0 | – | -200,000 | -100.0% | -0.13% | – |
| CSBR | Exit | CHAMPIONS ONCOLOGY | $0 | – | -4,471,180 | -100.0% | -0.14% | – |
| IMMU | Exit | IMMUNOMEDICS INC | $0 | – | -600,000 | -100.0% | -0.15% | – |
| IMMU | Exit | IMMUNOMEDICS INCput | $0 | – | -700,000 | -100.0% | -0.17% | – |
| MDGN | Exit | MEDGENICS INC | $0 | – | -465,225 | -100.0% | -0.17% | – |
| MGNX | Exit | MACROGENICS INC | $0 | – | -76,208 | -100.0% | -0.17% | – |
| RTRX | Exit | RETROPHIN INCput | $0 | – | -100,000 | -100.0% | -0.20% | – |
| RPTP | Exit | RAPTOR PHARMACEUTICAL CORP | $0 | – | -264,204 | -100.0% | -0.25% | – |
| NKTR | Exit | NEKTAR THERAPEUTICS | $0 | – | -335,000 | -100.0% | -0.25% | – |
| TTPH | Exit | TETRAPHASE PHARMACEUTICALS I | $0 | – | -100,000 | -100.0% | -0.29% | – |
| PTLA | Exit | PORTOLA PHARMACEUTICALS INC | $0 | – | -111,103 | -100.0% | -0.30% | – |
| ILMN | Exit | ILLUMINA INC | $0 | – | -25,000 | -100.0% | -0.33% | – |
| VTL | Exit | VITAL THERAPIES INCput | $0 | – | -300,000 | -100.0% | -0.38% | – |
| INSM | Exit | INSMED INC | $0 | – | -285,812 | -100.0% | -0.42% | – |
| Exit | SUPERNUS PHARMACEUTICALS INCnote 7.500% 5/0 | $0 | – | -2,187,000 | -100.0% | -0.42% | – | |
| CHRS | Exit | COHERUS BIOSCIENCES INC | $0 | – | -258,716 | -100.0% | -0.45% | – |
| SGMO | Exit | SANGAMO BIOSCIENCES INC | $0 | – | -800,000 | -100.0% | -0.53% | – |
| RCPT | Exit | RECEPTOS INC | $0 | – | -60,969 | -100.0% | -0.70% | – |
| PBYI | Exit | PUMA BIOTECHNOLOGY INCcall | $0 | – | -100,000 | -100.0% | -0.70% | – |
| HRTX | Exit | HERON THERAPEUTICS INC | $0 | – | -448,000 | -100.0% | -0.84% | – |
| MYL | Exit | MYLAN N V | $0 | – | -215,133 | -100.0% | -0.88% | – |
| ZBH | Exit | ZIMMER BIOMET HLDGS INC | $0 | – | -135,193 | -100.0% | -0.89% | – |
| RDUS | Exit | RADIUS HEALTH INC | $0 | – | -235,530 | -100.0% | -0.96% | – |
| ESPR | Exit | ESPERION THERAPEUTICS INCcall | $0 | – | -200,000 | -100.0% | -0.98% | – |
| CBPO | Exit | CHINA BIOLOGIC PRODS INC | $0 | – | -147,604 | -100.0% | -1.02% | – |
| AGN | Exit | ALLERGAN PLC | $0 | – | -59,185 | -100.0% | -1.08% | – |
| ZSPH | Exit | ZS PHARMA INC | $0 | – | -361,777 | -100.0% | -1.14% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
Signatures
The EDGAR filing(s) were signed by:
About Perceptive Advisors
Perceptive Advisors is a New York-based hedge fund that specializes in healthcare investments. The company was founded in 1999 by Joseph Edelman, who serves as the CEO and Chief Investment Officer. Since its inception, Perceptive Advisors has become one of the most successful healthcare-focused hedge funds in the world, with over $5 billion in assets under management.
The company's investment strategy is based on a deep understanding of the healthcare industry and a focus on identifying promising companies with innovative products and technologies. Perceptive Advisors invests in a wide range of healthcare sectors, including biotechnology, pharmaceuticals, medical devices, and healthcare services.
One of the key factors behind Perceptive Advisors' success is its team of experienced professionals. In addition to Joseph Edelman, the company's leadership team includes Adam Stone, the COO, and Jeremy Goldberg, the Chief Scientific Officer. The team also includes a group of highly skilled analysts and researchers who are experts in their respective fields.
Perceptive Advisors has a strong track record of generating high returns for its investors. However, it is important to note that investing in hedge funds carries significant risks, and investors should carefully consider their investment objectives and risk tolerance before investing. As with any investment, it is important to conduct thorough research and seek the advice of a qualified financial advisor before making any investment decisions.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| NEUROCRINE BIOSCIENCES SHARES | 42 | Q3 2023 | 15.7% |
| AMICUS THERAPEUTICS SHARES | 39 | Q3 2023 | 14.0% |
| ALDEYRA THERAPEUTICS SHARES | 35 | Q3 2023 | 3.3% |
| QUOTIENT TECHNOLOGY INC | 34 | Q3 2022 | 2.7% |
| GLOBAL BLOOD THERAPEUTICS SHARES | 29 | Q3 2022 | 9.3% |
| ADMA BIOLOGICS SHARES | 29 | Q3 2023 | 1.4% |
| RETROPHIN SHARES | 28 | Q3 2020 | 5.5% |
| DBV TECHNOLOGIES SA-SPON ADR | 28 | Q3 2021 | 1.8% |
| VBI VACCINES SHARES | 27 | Q1 2023 | 2.8% |
| IOVANCE BIOTHERAPEUTICS INC | 26 | Q3 2023 | 9.1% |
View Perceptive Advisors's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| CHEMBIO DIAGNOSTICS, INC.Sold out | May 04, 2023 | 0 | 0.0% |
| VBI Vaccines Inc/BC | April 07, 2023 | 43,509,553 | 16.7% |
| Landos Biopharma, Inc. | March 30, 2023 | 14,869,915 | 47.7% |
| REATA PHARMACEUTICALS INC | March 07, 2023 | 2,083,799 | 6.5% |
| AGILE THERAPEUTICS INCSold out | February 14, 2023 | 0 | 0.0% |
| ALBIREO PHARMA, INC. | February 14, 2023 | 1,757,160 | 8.5% |
| BELLUS Health Inc. | February 14, 2023 | 8,891,027 | 7.1% |
| CinCor Pharma, Inc. | February 14, 2023 | 2,576,325 | 5.9% |
| Coherus BioSciences, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| CONCERT PHARMACEUTICALS, INC. | February 14, 2023 | 1,800,000 | 3.6% |
View Perceptive Advisors's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13D/A | 2024-04-17 |
| SC 13D/A | 2024-04-17 |
| 4 | 2024-04-15 |
| SC 13G/A | 2024-04-15 |
| SC 13G | 2024-04-15 |
| SC 13D/A | 2024-04-10 |
| 4 | 2024-04-08 |
| 4 | 2024-04-03 |
| SC 13D/A | 2024-04-03 |
| SC 13D | 2024-03-20 |
View Perceptive Advisors's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.